Tag: axi-cel FL


Onclive25

FDA Approves Axi-Cel for Relapsed/Refractory Indolent Follicular Lymphoma

The FDA has granted an accelerated approval to axicabtagene ciloleucel for the treatment of adult patients with relapsed/refractory indolent follicular lymphoma after 2 or more lines of systemic therapy.

Visit website